Dear Client,
As part of our ongoing commitment to ensuring the security of your online trading experience, we would like to inform you of our protocol for addressing any suspicious activities observed on your trading account
Should you notice any irregularities or suspect unauthorized access to your account, we kindly request that you take immediate action by following the steps outlined below:
Send an Email Please send an email to stoptrade@acml.in from your registered email ID. In the email, briefly outline the suspicious activity you have observed.
Phone Call Alternatively, you can call us at 07965081981 Ext: 4 from your registered mobile number. This will enable us to address your concerns promptly.
When contacting us, please ensure you provide the following details:
By providing this information, you enable us to swiftly investigate and take appropriate measures to safeguard your account.
Your security and peace of mind are of utmost importance to us, and we appreciate your cooperation in maintaining the integrity of your trading account.
The company clarified that GMBU e.V. and its affiliates are not related to the promoter, promoter group, or group companies of Novelix Pharmaceuticals. The transaction does not fall under related-party transactions, and no promoter or promoter group entity has any interest in the agreement.
Novelix Pharmaceuticals is engaged in business of trading of pharmaceuticals and related products and is into the business of trading of shares and securities. The companys; consolidated net profit surged 405.56% to Rs 0.91 crore on 20.76% jump in revenue from operations to Rs 25.19 crore in Q4 FY26 over Q4 FY25.
The counter rallied 3.28% to end at Rs 54.40 n the BSE.
Powered by Capital Market - Live News